l General Information |
Product Name | TRx0237 mesylate |
General description | TRx 0237 mesylate is a second-generation tau protein aggregation inhibitor for the treatment of Alzheimer's disease (AD) and frontotemporal dementia. |
Synonym | Leucomethylene Blue Dimesylate; LMTX mesylate |
Purity | ≥98.5%(HPLC) | CAS Number | 1236208-20-0 |
Formula | C18H27N3O6S3 | Molecular Weight | 477.62 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25°C) | DMSO | ≥50mg/ml |
Ethanol | Insoluble |
Water | ≥50mg/ml |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
